FLASH NEWS LIVE

Bio-Rad Laboratories (NYSE:BIO) Price Target Lowered to $392.00 at Royal Bank of Canada

Bio-Rad Laboratories (NYSE:BIO) Price Target Lowered to $392.00 at Royal Bank of Canada

Bio-Rad Laboratories (NYSE:BIO) Price Target Lowered to $392.00 at Royal Bank of Canada

Bio-Rad Laboratories (NYSE:BIO – Free Report) had its target price decreased by Royal Bank of Canada from $409.00 to $392.00 in a research note published on Friday morning,Benzinga reports. Royal Bank of Canada currently has an outperform rating on the medica…

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.
Instagram Meta X LinkedIn Whatsapp